Exciting news! Translation-X got featured in BZ Baselland Zeitung! Special thanks to Stephanie Schnydrig
Translation-X
Biotechnologieforschung
Developing novel therapeutics for Autism Spectrum Disorders
Info
Translation-X is a spin-off project at the Biozentrum, University of Basel. We are developing novel pharmacological tools to reduce core symptoms of autism by targeting RNA translational machinery.
- Website
-
www.trx-therapeutics.com
Externer Link zu Translation-X
- Branche
- Biotechnologieforschung
- Größe
- 1 Beschäftigte:r
- Hauptsitz
- Basel
- Art
- Nonprofit
Orte
-
Primär
Wegbeschreibung
Spitalstrasse 41
Basel, CH
Updates
-
Translation-X hat dies direkt geteilt
Kicking innovation for safe energy transfer to life-saving implants, autism spectrum disorders treatment, and solar cells on railway tracks: COSKIN, Translation-X, and Sun-Ways advance to next stage of Venture Kick, receiving CHF 40,000 each. Congratulations to the teams of founders Andreas Kourouklis, Baptiste Danichert, Joseph Scuderi, Peter Scheiffele, Özgür Genç, and Guido Koch. https://lnkd.in/ezPjt696 COSKIN: Safe energy and data transfer in heart failure https://lnkd.in/eJuxPiQv Translation-X: Targeting selective mRNA translation for a precision medicine approach in autism spectrum disorders https://lnkd.in/eJ6NYfaG Sun-Ways: the new solar tracks https://lnkd.in/e5Z6mZ-V #SwissStartups #VentureKick
-
Translation-X hat dies direkt geteilt
Translational Academic Talk III by Özgür Genç (Translation-X, Biozentrum, University of Basel, University of Basel) “Targeting selective mRNA translation for a precision medicine approach in autism" Register Now & Submit Abstracts: http://rnatx.ch Please help spread the word!
-
-
Exciting times at Y-Science during Slush in Helsinki! Thanks to Swissnex and the Helsinki Institute of Life Science (HiLIFE), I had the opportunity to share the journey of our startup, Translation-X, at this remarkable gathering. Alongside many other startups, I presented our venture in autism therapeutics, highlighting the impactful work in the field. The Swiss booth at Slush was also amazing. It provided a fantastic opportunity to showcase Translation-X and discuss the exciting developments in our industry. During Slush, startups from the University of Helsinki had an impressive show. I'm confident that we can strengthen ties between Switzerland and Finland, fostering collaborations across universities and startups. A huge thanks to Swissnex and the Helsinki Institute of Life Science (HiLIFE) for the invitation. Looking forward to future collaborations and the positive impact we can create together! Translation-X Innovation Office University of Basel Biozentrum, University of Basel
-
-
-
-
-
2
-
-
Translation-X hat dies direkt geteilt
Kicking new innovation in CO2 capture, robotic material handling, pre-surgery decision-making, space mobility, infrastructure operation, and treatment of autism: Divea, Flink Robotics, Med4cast, peaKFlow, PAVE Space SA, and Translation-X win CHF 10,000 each, entering Venture Kick! Excited welcoming for the teams of entrepreneurs Mojtaba Chevalier, Kumar Varoon Agrawal, Karl Khalil, Moritz Geilinger, Simon Huber, Alexandre Lädermann, Philippe Collin, Patrick Denard, Frank Kolo, Heiner A. Weber, Serge Rovenne, Maximilien Renard, Tiago Salzmann, Yvan Bosshard, Rafael Monasterios, Peter Scheiffele, Özgür Genç, Guido Koch, Jérémy Marciacq, Pierre-Olivier Morin, Julie Böhning, Simon Both, and Lionel Isoz! https://lnkd.in/eJgsGtN8 Divea: Capturing CO2 at the source https://lnkd.in/e795jVyq Flink Robotics: Software intelligence for robotic material handling https://lnkd.in/eVjWJrTm Med4Cast: Revolutionizing pre-surgery decision-making by leveraging advanced AI diagnostics https://lnkd.in/eRuaSwhY PAVE Space SA: Revolutionize space mobility https://lnkd.in/eCJZHrfe peaKFlow: Turning Building Data into Actions https://lnkd.in/e6QCE_hg Translation-X: Targeting selective mRNA translation for a precision medicine approach in autism spectrum disorders https://lnkd.in/eJ6NYfaG #SwissStartups #VentureKick
Startups developing CO2 capture at the source, a software for robotic material handling, leveraging advanced AI diagnostics, revolutionizing space mobility, turning building data into actions, treating autism spectrum disorders each win CHF 10,000
venturekick.ch
-
Translation-X hat dies direkt geteilt
Excited to bring Translation-X to Y Science, highlighting breakthroughs in autism therapeutics.
Another special addition to this year's Y Science: a guest pitch from abroad, in our #health and #pharma session! 🇨🇭 We are partnering with Swissnex, the Swiss global network connecting #Switzerland and the world in #education, #research and #innovation. Their mission is to support the outreach and active engagement of their partners in the international exchange of knowledge, ideas and talent. With Swissnex support, Özgür Genç from the Biozentrum, University of Basel will be pitching Translation-X at Y Science stage 🎤 Özgür Genç is a #neuroscientist with a keen interest in understanding the genetic and pathological aspects of #autism. He initiated the Translation-X autism therapeutics project at the Biozentrum, University of Basel - an ambitious venture dedicated to developing novel therapies for autism. ❇ Register here to see him on stage (free and open for all): https://lnkd.in/dEKd8pSz Tatiana Benavides Damm, Lutz-Peter Berg, Gustav Henriksson, swisstech #yscience https://www.y-science.org/
-
-
I had an amazing time at the University of Applied Sciences and Arts Northwestern Switzerland FHNW, sharing the inspiring journey of Translation-X in the field of Autism Spectrum Disorders. We explored the path of turning scientific discoveries into practical solutions that make a real impact and benefit for society. It was truly energizing to connect with the bright students and draw inspiration from their enthusiasm. Special thanks to Prof. Oya Tagit for the invitation and to Prof. Eric Kübler for the engaging company during the seminar! #autism #startups #fhnw
-